Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Nvidia develops 6G radio chip as data center shifts stay on track - Jefferies
• KBAT Group files for 6.25M share IPO at $4-$5/sh